Antimicrobial susceptibility patterns of Escherichia coli phylogenetic groups isolated from bovine clinical mastitis

Journal of Dairy Science
Tiago TomaziMarcos Veiga Dos Santos

Abstract

Determination of antimicrobial susceptibility (AMS) of Escherichia coli causing clinical mastitis (CM) according to the phylogenetic groups and its association with descriptors at the cow and herd level may help improve specific strategies for treatment and control of this pathogen in dairy herds. The aims of the present study were to (a) determine the frequency of phylogenetic groups of E. coli isolated from CM in dairy cows, and its association with cow-level descriptors (parity, lactation stage, CM severity, and affected quarter position), housing system, and season; and (b) determine and compare AMS among E. coli phylogenetic groups. A quadruplex PCR method was used to classify E. coli isolates into 1 of the 7 phylogenetic groups. Minimal inhibitory concentrations were determined for 10 antimicrobials, and survival analysis was performed to evaluate the AMS differences among E. coli phylogroups. Most E. coli isolates belonged to phylogroups A (52%) and B1 (38%). None of the cow- and herd-level descriptors were associated with the E. coli phylogenetic groups. Overall, E. coli isolates were mostly susceptible to ceftiofur (96.8%), sulfadimethoxine (75.5%), and cephalothin (74.5%). Based on the survival analysis, differences i...Continue Reading

References

Sep 30, 2000·Applied and Environmental Microbiology·O ClermontE Bingen
Oct 15, 2003·Veterinary Research·Christian BurvenichLuc Duchateau
Aug 4, 2004·Veterinary Microbiology·P J Rajala-SchultzB C Love
Nov 11, 2005·Journal of the American Veterinary Medical Association·Fernanda G H Hoe, Pamela L Ruegg
Jul 18, 2006·Journal of the American Veterinary Medical Association·John R WenzGeorge M Barrington
Feb 23, 2008·Current Opinion in Microbiology·Nahum Y ShpigelIlan Rosenshine
Dec 9, 2008·Veterinary Microbiology·Björn BengtssonKarin Persson Waller
May 23, 2009·Foodborne Pathogens and Disease·Insook SonJeffrey S Karns
Jul 8, 2009·Research in Veterinary Science·Reza Ghanbarpour, Eric Oswald
Feb 17, 2010·Nature Reviews. Microbiology·Olivier TenaillonErick Denamur
Dec 25, 2010·Journal of Dairy Science·I R DohooUNKNOWN Mastitis Research Workers' Conference
Feb 18, 2011·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Olivier ClermontErick Denamur
Mar 1, 2012·Journal of Dairy Science·V SainiH W Barkema
Apr 19, 2012·Veterinary Microbiology·Belgin DoganKenneth W Simpson
May 1, 2013·American Journal of Veterinary Research·Cristina S CortinhasPamela L Ruegg
May 18, 2013·Journal of Veterinary Pharmacology and Therapeutics·L SuojalaS Pyörälä
Jul 7, 2014·Journal of Dairy Science·L Oliveira, P L Ruegg
Aug 26, 2015·Preventive Veterinary Medicine·C S F OliveiraJ P A Haddad
Jan 26, 2016·PloS One·Florent KempfPierre Germon
Jul 21, 2016·Scientific Reports·Robert J GoldstoneDavid G E Smith
May 10, 2017·BMC Genomics·Andreas LeimbachUlrich Dobrindt

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.